CompletedPhase 3NCT00121303
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Principal Investigator
- Jonathan Kell, MRCPathUniversity Hospital of Wales
- Intervention
- cytarabine(drug)
- Enrollment
- 600 enrolled
- Eligibility
- 61-120 years · All sexes
- Timeline
- 2005 – 2016
Study locations (6)
- North Hampshire Hospital, Basingstoke, England, United Kingdom
- Kent and Canterbury Hospital, Canterbury, England, United Kingdom
- Medway Maritime Hospital, Gillingham Kent, England, United Kingdom
- Maidstone Hospital, Maidstone, England, United Kingdom
- Royal Cornwall Hospital, Truro, Cornwall, England, United Kingdom
- University Hospital of Wales, Cardiff, Wales, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00121303 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.